CytomX Therapeutics, Inc. (CTMX)
2.985
0.00 (0.00%)
USD |
NASDAQ |
Jun 10, 09:54
CytomX Therapeutics Market Cap : 649.82M for June 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals, Inc. | 64.22B |
| Ocugen, Inc. | 421.21M |
| Catalyst Pharmaceuticals, Inc. | 3.831B |
| Rigel Pharmaceuticals, Inc. | 568.68M |
| iBio, Inc. | 60.80M |
Market Cap Related Metrics
| PS Ratio | 13.47 |
| Price to Book Value | 2.031 |
| Price | 2.985 |
| Earnings Yield | -12.18% |